[go: up one dir, main page]

WO2006004768A3 - Immortal cell lines containing non-mitochondrial genetic material within the mitochondria - Google Patents

Immortal cell lines containing non-mitochondrial genetic material within the mitochondria Download PDF

Info

Publication number
WO2006004768A3
WO2006004768A3 PCT/US2005/022958 US2005022958W WO2006004768A3 WO 2006004768 A3 WO2006004768 A3 WO 2006004768A3 US 2005022958 W US2005022958 W US 2005022958W WO 2006004768 A3 WO2006004768 A3 WO 2006004768A3
Authority
WO
WIPO (PCT)
Prior art keywords
cell lines
mitochondria
mitochondrial
lines containing
genetic material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/022958
Other languages
French (fr)
Other versions
WO2006004768A2 (en
Inventor
Sung Sup Park
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PAIK MEDICINE INTERNATIONAL Inc
PAIK MEDICINE INTERNATIONAL IN
Original Assignee
PAIK MEDICINE INTERNATIONAL Inc
PAIK MEDICINE INTERNATIONAL IN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PAIK MEDICINE INTERNATIONAL Inc, PAIK MEDICINE INTERNATIONAL IN filed Critical PAIK MEDICINE INTERNATIONAL Inc
Publication of WO2006004768A2 publication Critical patent/WO2006004768A2/en
Publication of WO2006004768A3 publication Critical patent/WO2006004768A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A new cell line has been established by previous methods of immortalization with EBV that contains the HCV RNA genome staff y within the mitochondria. Thus, a method for the introduction of non-mitochondrial material into mitochondrial, immortal cell lines, and methods of using the cell lines to produce mitochondrial proteins are presented. The methods are particularly useful for the production of cell lines containing viral genomes that have a part or all of their life cycle within the mitochondria.
PCT/US2005/022958 2004-06-28 2005-06-28 Immortal cell lines containing non-mitochondrial genetic material within the mitochondria Ceased WO2006004768A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58394504P 2004-06-28 2004-06-28
US60/583,945 2004-06-28

Publications (2)

Publication Number Publication Date
WO2006004768A2 WO2006004768A2 (en) 2006-01-12
WO2006004768A3 true WO2006004768A3 (en) 2006-08-24

Family

ID=35783321

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/022958 Ceased WO2006004768A2 (en) 2004-06-28 2005-06-28 Immortal cell lines containing non-mitochondrial genetic material within the mitochondria

Country Status (1)

Country Link
WO (1) WO2006004768A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200626724A (en) * 2004-08-23 2006-08-01 Paik Medicine International Inc Method for gene transfer into the organelles of cells: direct gene transfer to mitochondria

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100068A (en) * 1997-01-21 2000-08-08 Paik-Inje Memorial Institute For Biomedical Science Method of protein production using mitochondrial translation system

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100068A (en) * 1997-01-21 2000-08-08 Paik-Inje Memorial Institute For Biomedical Science Method of protein production using mitochondrial translation system

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
IKEDA ET AL.: "Analysis of the cell tropism of HCV by using in vitro HCV-infected human lymphocytes and hepatocytes", J. HEPATOL., vol. 27, no. 3, 8 August 2000 (2000-08-08), pages 445 - 454, XP001033876 *
SUNG ET AL.: "Establishment of B-Cell Lymphoma Cell Lines Persistently Infected with Hepatitis C Virus In Vivo and In Vitro: the Apoptotic Effects of Virus Infection", J. VIROL., vol. 77, no. 3, February 2003 (2003-02-01), pages 2134 - 2146, XP003000083 *

Also Published As

Publication number Publication date
WO2006004768A2 (en) 2006-01-12

Similar Documents

Publication Publication Date Title
ES2526191T3 (en) Method to produce infectious influenza B virus in cell culture
Tóth-Petróczy et al. The robustness and innovability of protein folds
EP1697521A4 (en) Multi plasmid system for the production of influenza virus
PL1646715T3 (en) Production of poxviruses with adherent or non adherent avian cell lines
WO2005042728A3 (en) Immortalized avian cell lines for virus production
CY1107014T1 (en) USE OF FREE MEDICINAL MEDICINAL MEDICINAL PRODUCTION FOR IL-18BP PRODUCTION IN Mammalian Cells
MX2021000211A (en) Methods and products for transfecting cells.
RU2012103038A (en) DNA INTEGRATION IN PLANT CELLS
ATE414144T1 (en) CULTURES OF E1-IMMORALIZED CELLS AND METHOD FOR CULTIVATION THEM TO INCREASE THE PRODUCT YIELDS THEREOF
CA2851807A1 (en) Nucleic acid construct containing full length genome of human hepatitis c virus, recombinant full length virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis c virus particle
MX2010001319A (en) Method of producing heterogeneous protein.
EA201492202A1 (en) METHOD OF EXPRESSION OF HETEROLOGICAL PROTEINS USING A RECOMBINANT VIRAL VECTOR WITH RNA MINUS THREAD
AU2007240448A8 (en) Methods and compositions for expressing negative-sense viral RNA in canine cells
WO2007048089A3 (en) Multi-plasmid system for the production of influenza virus
CY1111253T1 (en) METHOD FOR PRODUCTION OF VIRUS MATERIAL
WO2006038129A3 (en) Hepatitis c virus replication system
ATE507293T1 (en) CONSERVED HBV AND HCV SEQUENCES SUITABLE FOR GENE SILENCING
WO2006004768A3 (en) Immortal cell lines containing non-mitochondrial genetic material within the mitochondria
WO2003049767A3 (en) Method of large scale production of hepatitis a virus
Huang et al. The 3′-terminal hexamer sequence of classical swine fever virus RNA plays a role in negatively regulating the IRES-mediated translation
WO2014033546A3 (en) Methods for producing cells having a phenotype of a primary human hepatocytes and compositions
WO2008136470A1 (en) Hcv gene
SI1950307T1 (en) Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with rna virus spike protein
Kobayashi et al. An improved cell-free system for picornavirus synthesis
Kulsuptrakul et al. A CRISPR screen identifies UFMylation and TRAMP-like complexes required for hepatitis A virus infection

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase